What's Wrong With Vertex Pharmaceuticals Stock?
Vertex Pharmaceuticals (NASDAQ: VRTX) has been a top pharma stock in recent years. It has been generating strong revenue growth while also building out its portfolio of drugs, expanding its growth opportunities in the process. This is the type of stock that you might expect to see taking off this year.
But that isn't happening.
Instead, the share price of Vertex recently plunged. Excitement around the company has cooled drastically. What's wrong with Vertex Pharmaceuticals, and is it an investment worth buying on the dip, or could there be more trouble ahead for the healthcare stock?
Source Fool.com
Vertex Pharmaceuticals Inc. Stock
€390.60
0.370%
With 39 Buy predictions and not a single Sell prediction Vertex Pharmaceuticals Inc. is an absolute favorite of our community.
As a result the target price of 458 € shows a slightly positive potential of 17.26% compared to the current price of 390.6 € for Vertex Pharmaceuticals Inc..
